201 related articles for article (PubMed ID: 10950264)
1. Sleep attacks in Parkinson's disease.
Pirker W; Happe S
Lancet; 2000 Aug; 356(9229):597-8. PubMed ID: 10950264
[No Abstract] [Full Text] [Related]
2. [Sleep attacks and pergolide mesylate].
García Ruiz PJ; Hernández J; Cantarero S; Fanjul S
Neurologia; 2001 Feb; 16(2):92. PubMed ID: 11257938
[No Abstract] [Full Text] [Related]
3. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease.
Paus S; Brecht HM; Köster J; Seeger G; Klockgether T; Wüllner U
Mov Disord; 2003 Jun; 18(6):659-67. PubMed ID: 12784269
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials.
Etminan M; Samii A; Takkouche B; Rochon PA
Drug Saf; 2001; 24(11):863-8. PubMed ID: 11665873
[TBL] [Abstract][Full Text] [Related]
5. Piribedil-induced sleep attacks in Parkinson's disease.
Tan EK
Fundam Clin Pharmacol; 2003 Feb; 17(1):117-9. PubMed ID: 12588638
[TBL] [Abstract][Full Text] [Related]
6. Duration of L-dopa and dopamine agonist monotherapy in Parkinson's disease.
Nissen T; Newman EJ; Grosset KA; Daghem M; Pal G; Stewart M; Odin P; Macphee GJ; Grosset DG
Scott Med J; 2012 Nov; 57(4):217-20. PubMed ID: 23002158
[TBL] [Abstract][Full Text] [Related]
7. Pramipexole, ropinirole, and mania in Parkinson's disease.
Singh A; Althoff R; Martineau RJ; Jacobson J
Am J Psychiatry; 2005 Apr; 162(4):814-5. PubMed ID: 15800169
[No Abstract] [Full Text] [Related]
8. Comparing dopamine agonists in Parkinson's disease.
Bonuccelli U
Curr Opin Neurol; 2003 Dec; 16 Suppl 1():S13-9. PubMed ID: 15180133
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks".
Rissling I; Geller F; Bandmann O; Stiasny-Kolster K; Körner Y; Meindorfner C; Krüger HP; Oertel WH; Möller JC
Mov Disord; 2004 Nov; 19(11):1279-84. PubMed ID: 15390060
[TBL] [Abstract][Full Text] [Related]
10. Sleep attacks--facts and fiction: a critical review.
Homann CN; Wenzel K; Suppan K; Ivanic G; Crevenna R; Ott E
Adv Neurol; 2003; 91():335-41. PubMed ID: 12442691
[No Abstract] [Full Text] [Related]
11. A placebo-controlled study of ropinirole, a new D2 agonist, in the treatment of motor fluctuations of L-DOPA-treated parkinsonian patients.
Rascol O; Lees AJ; Senard JM; Pirtosek Z; Brefel C; Montastruc JL; Fuell D
Adv Neurol; 1996; 69():531-4. PubMed ID: 8615176
[No Abstract] [Full Text] [Related]
12. Excessive daytime sleepiness in Parkinson's disease.
Schapira AH
Neurology; 2004 Oct; 63(8 Suppl 3):S24-7. PubMed ID: 15505139
[No Abstract] [Full Text] [Related]
13. Heart valve abnormalities in Parkinson's disease treated with dopamine agonists.
Bares M; Rektorová I; Krajcovicová L; Rektor I
J Neurol; 2008 Oct; 255(10):1596; author reply 1597. PubMed ID: 18758889
[No Abstract] [Full Text] [Related]
14. Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known?
Zesiewicz TA; Hauser RA
CNS Drugs; 2003; 17(8):593-600. PubMed ID: 12775195
[TBL] [Abstract][Full Text] [Related]
15. Ropinirole in the symptomatic treatment of Parkinson's disease.
Brooks DJ; Torjanski N; Burn DJ
J Neural Transm Suppl; 1995; 45():231-8. PubMed ID: 8748630
[TBL] [Abstract][Full Text] [Related]
16. Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists.
Del Dotto P; Gambaccini G; Caneparo D; Berti C; Bernardini S; Bonuccelli U
Neurol Sci; 2003 Oct; 24(3):170-1. PubMed ID: 14598071
[TBL] [Abstract][Full Text] [Related]
17. Excessive daytime sleepiness in parkinsonism.
Arnulf I
Sleep Med Rev; 2005 Jun; 9(3):185-200. PubMed ID: 15893249
[TBL] [Abstract][Full Text] [Related]
18. Daytime sleepiness, agonist therapy, and driving in Parkinson disease.
Comella CL
JAMA; 2002 Jan 23-30; 287(4):509-11. PubMed ID: 11798375
[No Abstract] [Full Text] [Related]
19. Pramipexole and ropinirole for Parkinson's disease.
Med Lett Drugs Ther; 1997 Nov; 39(1014):109-10. PubMed ID: 9398824
[No Abstract] [Full Text] [Related]
20. Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease.
Ahlskog JE
Physiol Behav; 2011 Jul; 104(1):168-72. PubMed ID: 21557955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
